Sales efforts will address access to ECG screening through pharmacies and primary care physician offices in Eastern Canada
TORONTO, ONTARIO – CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) a global medical and consumer provider of electrocardiogram (“ECG”) acquisition and management software solutions, today announced it has engaged Nu-Quest Distribution Inc. (“Nu-Quest”), located in Mount Pearl, Newfoundland as its Eastern Canada medical technology distributor.
Nu-Quest will be responsible for development and management of sales and distribution channels for the sale of CardioComm Solutions’ HeartCheck™ ECG technologies as well as the Company’s ECG management software known as the Global ECG Management System for Windows (GEMS™ WIN) through hospitals, clinics and health care providers within Newfoundland and Labrador.
Nu-Quest Distribution Inc. is a Newfoundland and Labrador family owned and operated pharmaceutical wholesaler that was founded in 1996, whose motto is “Putting your customers first”. Nu-Quest distributes Canadian Federally approved medications, medical equipment, supplies and accessories serving pharmacies, physicians, hospitals, clinics and veterinarians. They are a registered member of the Canadian Association for Pharmacy Distribution Management (CAPDM).
A Nu-Quest representative commented that, “Nu-Quest serves approximately 150 local pharmacies and a number of physician offices. Newfoundland is a unique province geographically and for most living there, hospitals and clinics are miles away. The HeartCheck™ ECG monitor would provide an added value to patients of the province who have heart conditions by allowing them to be able to monitor their heart rhythm and ECG without having to leave the comfort of their own home. We are pleased to introduce the HearthCheck™ ECG PEN to our portfolio and providing access to patients is our main goal”.
CardioComm Solutions is intent on providing cutting edge technology for use in locations where large urban or university based hospitals and tertiary centers are less available. Through the Company’s HeartCheck™, SMART Monitoring ECG Service, GEMS™ WIN and the recently announced GEMS™ Home Rx for physician use, CardioComm Solutions will provide access to their cardiology-based GEMS™ software for the remote monitoring of patients and consumers for extended periods of time while outside the environment of a hospital or physician’s office and while and engaged in their daily lives.
This is the fourth strategic partnership reported by CardioComm Solutions since July and the Company has stated that more will be announced as sales from new distributors are confirmed. To learn more about the CardioComm Solutions products and devices compatible with GEMS™ WIN please see the Company’s website www.cardiocommsolutions.com or contact the Company at [email protected].